FDA Drug Recalls

Recalls / Class II

Class IID-0900-2023

Product

Allergy, Fexofenadine Hydrochloride Tablets, 180 mg, packaged in a) 30-count cartons (NDC 72288-847-39), and b)150-count cartons (NDC 72288-847-47 and 72288-847-37), Distributed By: Amazon.com Services LLC., 410 Terry Avenue N., Seattle, WA 98109.

Brand name
Basic Care Allergy
Generic name
Fexofenadine Hydrochloride
Active ingredient
Fexofenadine Hydrochloride
Route
Oral
NDC
72288-847
FDA application
ANDA212971
Affected lot / code info
Lot # a) 2GR0329, Exp. date 04/24 Lot # b) 2DR0472, Exp. date 02/23; 2MR0417, Exp. date 07/24

Why it was recalled

Failed Impurities/Degradation Specifications

Recalling firm

Firm
L. Perrigo Company
Manufacturer
Amazon.com Services LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
515 Eastern Ave, N/A, Allegan, Michigan 49010-9070

Distribution

Quantity
11,904 cartons
Distribution pattern
Nationwide within the USA

Timeline

Recall initiated
2023-02-09
FDA classified
2023-07-11
Posted by FDA
2023-07-19
Terminated
2023-09-11
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0900-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.